Clinical characteristics of non-obese children with type 2 diabetes mellitus without involvement of β-cell autoimmunity

Diabetes Research and Clinical Practice

Volumn 99, Issue 2, 2013, Pages 105-111

  Urakami, Tatsuhiko ^a   Kuwabara, Remi ^a   Habu, Masako ^a   Okuno, Misako ^a   Suzuki, Junichi ^a   Takahashi, Shori ^a   Mugishima, Hideo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell autoimmunity; Children; Insulin resistance; Insulin secretory capacity; Non obese type 2 diabetes mellitus

Indexed keywords

ALBUMIN; ALPHA GLUCOSIDASE INHIBITOR; CREATININE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ARTICLE; AUTOIMMUNITY; CHILD; CHILDHOOD OBESITY; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC DIET; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; FAMILY HISTORY; FEMALE; GLUCOSE URINE LEVEL; GLUCOSURIA; HEALTH PROGRAM; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; KINESIOTHERAPY; LARGE FOR GESTATIONAL AGE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; SCHOOL CHILD; SCREENING TEST;

ADOLESCENT; ADULT; AUTOIMMUNITY; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; OBESITY; YOUNG ADULT;

EID: 84876708429     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.11.021     Document Type: Article

References (40)

1. Rosenbloom A.L., Silverstein J.H., Amemiya S., Zeitler P., Kingensmith G.J. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes 2008, 9:512-526.
2. Shaw J. Epidemiology of childhood type 2 diabetes and obesity. Pediatr Diabetes 2007, 8(Suppl. 9):7-15.
3. Low L.C.K. The epidemic of type 2 diabetes mellitus in the Asia-Pacific region. Pediatr Diabetes 2010, 11:212-215.
4. Urakami T., Kubota S., Nitadori Y., Harada K., Owada M., Kitagawa T. Annual incidence and clinical characteristics of type 2 diabetes in school children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 2005, 28:1876-1881.
5. Urakami T., Morimoto S., Nitadori Y., Harada K., Owada M., Kitagawa T. Urine glucose screening program at schools in Japan to detect children with diabetes and its outcome: incidence and clinical characteristics of childhood type 2 diabetes in Japan. Pediatr Res 2007, 61:141-145.
6. Ogihara T., Mirmira R.G. An islet in distress: β cell failure in type 2 diabetes. J Diabetes Invest 2010, 1:123-133.
7. Yamanouchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
8. Lihn A.S., Pederson S.B., Richeksen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005, 6:13-21.
9. Taniguchi A., Nakai Y., Fukushima M., Kawamura H., Imura H., Nagata I, et al. Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 1992, 41:1540-1546.
10. Kobayashi K.o., Amemiya S., Higashida K., Ishihara T., Sawanobori E., Kobayashi K.i., et al. Pathogenic factors of glucose intolerance in obese Japanese adolescents with type 2 diabetes. Metabolism 2000, 49:186-193.
11. Sugihara S., Sasaki N., Kohno H., Amemiya S., Tanaka T., Matsuura N. Survey of current medical treatments for childhood-onset type 2 diabetes mellitus in Japan. Clin Pediatr Endocrinol 2005, 14:65-75. The Committee for Medical Treatment of Childhood-onset Type 2 Diabetes Mellitus. The Japanese Society for Pediatric Endocrinology.
12. Urakami T. How should we treat type 2 diabetes in youth?. Pediatr Endocrinol Rev 2005, 3:33-39.
13. Asayama K., Ozeki T., Sugihara S., Ito K., Okada T., Tamai H., et al. Criteria for medical intervention in obese children: a new definition of obesity disease in Japanese children. Pediatr Int 2003, 45:642-646.
14. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
15. Kuzuya T., Nakagawa S., Satoh J., Kanazawa W., Iwamoto Y., Kobayashi M., et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002, 55:65-85.
16. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 2002, 1:2-20.
17. Sugihara S., Sasaki N., Amemiya S., Kohno H., Tanaka T., Matsuura N. Analysis of birth weight at birth and at diagnosis of childhood-onset type 2 diabetes mellitus in Japan. Pediatr Diabetes 2008, 9:285-290. On behalf of the Committee for the Medical Treatment of Childhood-Onset Type 2 Diabetes Mellitus. The Japanese Society for Pediatric Endocrinology.
18. Pinhas-Hamiel O., Zeitler P. Clinical presentation and treatment of type 2 diabetes in children. Pediatr Diabetes 2008, 8(Suppl. 9):16-27.
19. Lee W.W.R. An overview of pediatric obesity. Pediatr Diabetes 2007, 8(Suppl. 9):76-87.
20. Ramachadran A., Snehalatha C., Satyavani K., Sivasankari n.S., Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care 2003, 26:1022-1023.
21. Weijin S., Sung F.C., Li C.Y., Chang C.H., Lin R.S., Lin C.C., et al. Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among school children in Taiwan. Diabetes Care 2003, 26:343-348.
22. Yoon K.H., Lee J.H., Kim J.W., Cho J.H., Choi Y.H., Ko S.H., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006, 368:1681-1688.
23. Chan J.C.N., Malik V., Jin W.P., Kadowaki T., Yajnik C.S., Yoon K.H., et al. Diabetes in Asia. Epidemiology, risk factors and pathology. J Am Med Assoc 2009, 301:2129-2140.
24. Tfayli H., Bacha F., Gungor N., Arslanian A. Phenotypic type 2 diabetes in obese youth; insulin sensitivity and secretion in islet-cell antibody negative vs. antibody positive patients. Diabetes 2009, 58:738-744.
25. American Diabetes Association Type 2 diabetes in children and adolescents. Diabetes Care 2000, 23:381-389.
26. Saad R.J., Danadian K., Lewy V., Arslanian S.A. Insulin resistance of puberty in African-American children: lack of a compensatory increase in insulin secretion. Pediatr Diabetes 2002, 3:4-9.
27. Morimoto S., Urakami T. Insulin resistance during puberty in non-obese Japanese children. Clin Pediatr Endocrinol 2011, 20:1-6.
28. Urakami T., Habu M., Kuwabara R., Komiya K., Nagano N., Suzuki J., et al. Insulin resistance at diagnosis in Japanese children with type 2 diabetes. Pediatr Int 2012, 54:516-519.
29. Schwartz B., Jacobs D.R., Moran A., Steinberger J., Hong C.P., Sinaiko A.R. Measurement of insulin sensitivity in children: comparison between the euglycemic-hyperinsulinemic clamp and surrogate measures. Diabetes Care 2008, 31:783-788.
30. Cutfield W.S., Jefferies C.A., Jackson W.E., Robinson E.M., Hofman P.L. Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr Diabetes 2003, 4:119-125.
31. Nguyen Q.M., Srinivasan S.R., Xu J.-H., Chen W., Kieltyka L., Berenson G.S. Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors. Diabetes Care 2010, 33:670-675.
32. d'Annunzio G., Vanilli M., Pistorio A., Minuto N., Bergamino L., Iafusco D., et al. Insulin resistance and secretion indexes in healthy Italian children and adolescents study. Acta Biomed 2009, 80:21-28.
33. Levy-Marchal C., Arslanian S., Cutfield W., Sinaiko A., Druet C., Marcovecchio M.L., et al. Insulin resistance in children: consensus, perspective, and future direction. J Clin Endocrinol Metab 2010, 95:5189-5198.
34. Turner R., Stratton I., Horton V., Manley S., Zimmer P., Mackay I.R., et al. UKPDS 25 autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes, UK Prospective Diabetes Study Group. Lancet 1997, 350:1288-1293.
35. Writing Group for the SEARCH for Diabetes in Youth Study Group Incidence of diabetes in youth in the United States. J Am Med Assoc 2007, 297:2716-2724.
36. Klingensmith G.J., Pyle L., Arslanian S., Copeland K.C., Cuttler L., Kaufman F., et al. The prevalence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype. Results from the TODAY Study. Diabetes Care 2010, 33:1970-1975. For the TODAY Study Group.
37. Pozzilli P., Guglielmi C. Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Endocr Dev 2009, 14:151-166.
38. Urakami T., Miyamoto Y., Fujita H., Kitagawa T. Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease. Diabetologia 1989, 32:312-315.
39. Urakami T., Matsunaga H., Miyamoto Y., Owada M., Kitagawa T. Serial changes in the prevalence of islet cell antibodies and islet cell antibody titer in children with IDDM of abrupt or slow onset. Diabetes Care 1995, 18:408-413.
40. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. β-Cell deficit and increased β-cell apoptosis in human with type 2 diabetes. Diabetes 2003, 52:102-110.